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1. Introduction 
Fibromyalgia Syndrome (FMS) is one of the most frequent rheumatologic conditions, its 
main characteristic being chronic diffuse musculoskeletal pain and hyperalgesia, likely due 
to altered central processing of pain (1). Fibromyalgia symptoms are not restricted to pain. 
Besides the painful setting, these patients often complain of fatigue, sleep disturbances, 
morning stiffness, and paresthesia on the extremities, subjective edema sensations and 
cognitive disturbances. Many patients experience cognitive dysfunction known as "fibrofog" 
which may be characterized by impaired concentration. Cognitive symptoms in these 
patients may be exacerbated by the presence of depression, anxiety, sleep problems, 
endocrine disturbances, and pain. 
Association with other comorbidities is often found, contributing to the suffering and 
decline in quality of life of these patients. Among the most frequent comorbidities found, it 
can be mentioned depression, anxiety, chronic fatigue syndrome, myofascial syndrome, 
irritable bowel syndrome and nonspecific urethral syndrome (2). 
Various researches show that there were relation between chronic pain and cognitive 
dysfunction in FM patients. Managing chronic pain may take some cognitive effort and this 
may interfere with performance on cognitive tasks. This is important because even though 
FMS patients report cognitive symptoms, physicians and scientists must consider the 
possibility that because FM patients experience many symptoms, there may be a tendency to 
mistake normal, everyday lapses on cognition as something more serious (3).  
2. Relational issues and alexithyma 
It has been argued that alexithymia is one of the major disturbances about cognitive 
difunction. The core disturbance in alexithymia is a deficit in the cognitive processing and 
regulation of emotions. Thus, some of the emotional and behavioural disturbances 
associated with fibromyalgia may reflect the presence of alexithymia. (4)  
The high rate of alexithymia as well as anxiety and depression may be seen in FMS patients. 
Several reports reveal the existence of a relationship between alexithymia, depression and 
anxiety. Hendryx et al. (5) suggested that alexithymia is multidimensional feature. They also 
reported that alexithymia was related to generalized anxiety and depression. Anxiety and 
depression are often precedes or manifest after fibromyalgia.  
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3. The etiology of alexithymia 
Although environmental, neurological, and genetic factors are each involved, the role of 
genetic and environmental factors for developing alexithymia is still unclear. 
Alexithymia is considered to be a personality trait. It seems to have a connection with 
several chronic conditions including FMS. Muftuoglu et al. (6) studied alexithymic features 
and affective states in migraine patients and found that migraine patients were significantly 
more depressive, anxious, and alexithymic than the control group. Also Yucel et al. (7) 
studied depression and alexithymia in patients with tensiontype headache. They found that 
compared to healthy controls, the subjects with headaches had significantly higher scores on 
measures of depression and alexithymia. However, to date, a clear correlation between 
alexithymia and pain has not been established (8). 
The term “alexithymia” derived from the Greek words “a” (lack), “lexis” (word), and 
“tymos” (emotion). It was first introduced by Sifneos in 1972 (9). The original definition of 
alexithymia is difficulties to identifying and describing feelings (10). Alexithymia is a 
multifaceted personality construct characterized by a reduced ability the emotions and a 
tendency to utilize an externally-focused.  
Some researchers hypothesized that alexithymia is associated with brain abnormalities (11, 
12). Neuroimaging studies found that alexithymia may be associated with a higher level 
cognitive deficit in estimating emotional inputs rather than a lack of neuronal response in 
structures representing lower level processing of emotional stimuli (13). Biopsychosocial 
model including psychological factors as well as factors related to perturbation of the 
autonomic nervous system and the HPA-axis explained a substantial part of variance of 
pain in the fibromyalgia patients. Psychological distress was strongly associated with 
perceived pain, and only affective pain was found to be associated with autonomic 
reactivity.  
An early theory of pain localization in the CNS was the gate control theory (14). A goal of 
this theory was to provide mechanisms whereby one differentiates between innocuous and 
noxious stimulation. Inherent to this undertaking was the effort to explain two cognitive 
domains of pain processing; sensory-discriminative and affective-motivational. The concept 
of a duality in CNS pain processing was amplified by Albe-Fessard et al. (15) who suggested 
these domains are differentially localized in the thalamus. The lateral nuclei were thought to 
mediate sensory-discrimination and the medial nuclei the affective-motivational component 
of processing. Although its likely these functions are subserved in part by the two thalamic 
divisions as proposed, accounting for multiple aspects of the conscious experience of pain 
with thalamic mechanisms alone is difficult. Particularly in light of the prominent 
projections of the medial and lateral thalamic nuclei to different parts of the cerebral cortex 
and the role of the cortex in anticipation and memory of many events including those 
associated with painful experiences. Indeed, one of the main functions of cortical pain 
processing is integrating the pain experience with other cortical information processing 
functions. A complete model of the medial and lateral systems, therefore, requires 
consideration of many cortical areas that are involved in such functions in addition to 
thalamic sites. (16 ) 
It has long been known that ablations of cingulate cortex (cingulotomy lesions) or its 
underlying white matter (cingulumotomy lesions) alleviate pain in chronic conditions. In 
Neurobiology of Cingulate Cortex and Limbic Thalamus (17), it was proposed that 
projections of the midline and intralaminar thalamic nuclei to Anteror cingulate cortex 
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provided a cortical substrate for the affective-motivational aspects of pain processing. 
Nociceptive stimuli may evoke brain responses longer than the stimulus duration often 
partially detected by conventional neuroimaging. Fibromyalgia patients typically complain 
of severe pain from gentle stimuli.  
Anterior cingulate cortex, for example, has been shown to play an essential role in pain 
perception and pain control, brain imaging studies in FMS patients point to alterations in 
regional cerebral blood flow (18, 19). 
Early studies showed evidence that there may be an interhemispheric transfer deficit among 
alexithymics; that is, the emotional information from the right hemisphere is not being 
properly transferred to the language regions in the left hemisphere, as can be caused by a 
decreased corpus callosum, often present in psychiatric patients who have suffered severe 
childhood abuse. 
A neuropsychological study indicated that alexithymia may be due to a disturbance to the 
right hemisphere of the brain, which is largely responsible for processing emotions (20). In 
addition, another neuropsychological model suggests that alexithymia may be related to a 
dysfunction of the anterior cingulate cortex (21). These studies have some shortcomings 
however, and the empirical evidence about the causes of alexithymia remains inconclusive 
(22). It has been reported that there were strong focus by clinicians on neurophysiological at 
the expense of psychological explanations for the genesis and operation of alexithymia, and 
introduced the alternative term "disaffectation" to stand for psychogenic alexithymia. The 
disaffected individual had at some point "experienced overwhelming emotion that 
threatened to attack their sense of integrity and identity", to which they applied 
psychological defenses to pulverize and eject all emotional representations from 
consciousness (23). 
Alexithymia has also been found to be related to dysfunction in the posterior cingulate 
cortex during various mental imagery conditions (24). Lane et al. (25) stressed the core 
feature of alexithymia as a deficit in conscious awareness of emotions (e.g., differentiating, 
symbolizing emotions and appreciating complexity in the experience of self and other). 
Thus, alexithymia refers to impairment in not only affective but also cognitive emotional 
processing. 
All attempts at elucidating the etiology of alexithymia must be considered theoretical and 
speculative. Since the clinical criteria and measurement of alexithymia have not been 
standardized, it seems premature to be focusing exclusively on etiological models. 
However, theoretical speculations may lead to testable hypotheses, which could then serve 
to validate the concept itself. 
4. Prevalence of alexithymia 
In studies of the general population the degree of alexithymia was found to be influenced by 
age, but not by gender; the rates of alexithymia in healthy controls have been found at: 4.7%- 
8.3%. Thus, several studies have reported that the prevalence rate of alexithymia is less than 
10% (26). A less common finding suggests that there may be a higher prevalence of 
alexithymia amongst males than females, which may be accounted for by difficulties some 
males have with "describing feelings", but not by difficulties in "identifying feelings" in 
which males and females show similar abilities.  
Studies reported a distinct gender difference in the prevalence of alexithymia: men were 
alexithymic almost twice as often as women. A similar gender difference was found in the 
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previous study using the Beth Israel Questionnaire (BIQ). The study by Parker et al. (27) 
using the Toronto Alexithymia Scale (TAS), and covering three samples of young adults in 
Canada, the United States, and Germany, showed similar correlations between alexithymia 
and gender. On the other hand, the Italian study by Pasini and coworkers (28) using the TAS 
showed no gender difference in alexithymia, but it must be pointed out that their study 
group consisted of healthy volunteers. It seems likely that alexithymia is a personality trait 
that is more typical of men than women. 
5. Clinical approach to alexithymia 
Individuals with alexithymia are typically unable to identify, understand, or describe their 
own emotions. Psychiatric and psychosomatic patients with alexithymia are unable to talk 
about feelings due to a lack of emotional selfawareness (29). Self-awareness is a fundamental 
aspect of empathy because the individual’s recognition of their own feelings is the basis for 
identification with the feelings of others. 
Alexithymia is defined by Parker  
1. difficulty identifying feelings and distinguishing between feelings and the bodily 
sensations of emotional arousal  
2. difficulty describing feelings to other people  
3. constricted imaginal processes, as evidenced by a scarcity of fantasies  
4. a stimulus-bound, externally oriented cognitive style.  
It supposed to be there were two kinds of alexithymia, "primary alexithymia" which is an 
enduring psychological trait that does not alter over time, and "secondary alexithymia" 
which is state-dependent and disappears after the evoking stressful situation has changed. 
These two manifestations of alexithymia are otherwise called "trait" or "state" alexithymia. 
The study regarding with alexithymia and depression by Steinweg et al. (30) reported that 
“Aleithymia may be more of a state than a trait”. 
Several authors have suggested that alexithymia was elevated in numerous 
psychosomatic and medical conditions such as rheumatoid arthritis, low-back pain, and 
hypertension. Furthermore, alexithymia has been shown to prospectively predict the 
maintenance of summarization over a period of two years. Alexithymia is especially 
related with medical disorders thought to be primarily caused or maintained by 
psychological factors.  
There is some evidence suggesting that alexithymia is related to chronic pain. In addition to 
chronic, other aspects of pain such as severity may be related to alexithymia. It has proposed 
that chronic pain consist two components sensory and affective. Alexithymia is related to 
the affective-rather than the sensory-dimension of chronic pain, and this association could 
be mediated by increased depression. Several studies have been reported that affective 
dimension of the pain was predominant in fibromyalgia. Depressive mood is the best 
predictor of the affective dimension of the pain, whereas depression is a significant clinical 
component of fibromyalgia.  
Depression has been widely studied in both the chronic pain and alexithymia fields. Chronic 
pain is often comorbid with depression, and alexithymia is also substantially related to 
depression and may predispose to it. These observations suggest that depression may 
mediate the correlation between alexithymia and chronic pain. In a various study relation 
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was found between alexithymia anxiety and depression, which may indicate that 
alexithymia scores may be associated with psychological distress. They argued that 
treatment-seeking behavior may be more commonly. In the light of the several literatures it 
thought to be the psychiatric evaluation of fibromyalgia patients is as important as the 
locomotor system evaluation. 
Fibromyalgia is considered one of the more difficult chronic pain syndromes to deal with. 
The chronic pain in fibromyalgia had been severe enough to disrupt all aspects of the 
patient’s life. It has been proposed that abnormal pain sensitivity and pain inhibition in 
fibromyalgia. Abnormal pain perception might be related to abnormal levels of serotonin 
and norepinephrine, which are key neurotransmitters in endogenous pain inhibitory 
pathways. 
According to the model of neuropathic pain, sensitivity of pain is reduced when the source 
is eliminated. In contrast, the source of sensory input among patients with fibromyalgia 
remains unknown. There is increasing evidence that fibromyalgia is characterized by an 
augmentation of sensory input that is mediated by central nervous system (CNS) events 
similar to those associated with neuropathic pain conditions. For this reason, most 
investigators involved in fibromyalgia research refer to central augmentation of sensory 
input rather than central sensitization when they discuss the pathophysiology of 
fibromyalgia.  
Patients with fibromyalgia have difficulty to identify self expression. It has been suggested 
that difficulty to description of complaints may associated with alexithymic personality 
characterized by inability to differentiate affective from somatic states (31). Patients with 
alexithymia have also manifest cognitive characteristics such as paucity of fantasy, imagery, 
or daydreaming. Consequently, due to the difficulty to experience and express emotions, 
alexithymia has been linked with somatosensory amplification, which is tendency to focus 
on somatic sensations.  
Fibromyalgia is thought to arise from miscommunication among nerve impulses in the 
central nervous system, in other words, the brain and spinal cord. It has been postulated 
that a disconnection between neocortex and the limbic system occurs and causes difficulty 
verbalizing feelings and regulating affect. Alexithymia is thought to impede the regulation 
of negative emotions, resulting in increased negative affect, sympathetic hyperarousal, and 
impaired immune status, which may contribute to development or exacerbation of somatic 
disease and pain (32). 
Alexithymia does not emerge as a product of pain, but rather is intrinsic to this illness. 
Alexithymia has been reported to be associated with enhanced sensitivity not only to 
somatic sensations, but also to externally induced pain. Increased alexithymia may effects 
the nature of assessment and treatment the chronic pain.  
6. Measurement of alexithymia 
Along with the clinical descriptions of alexithymia, there have been attempts to objectify 
and operationalize the concept in some measurable way. 
Alexithymia may be measured as a valid and reliable clinical phenomenon (12). However, it 
is a difficult concept to operationally and only few instruments are sufficiently reliable and 
valid. Several scales are used to measure alexithymia but only the Beth Israel Questionnaire 
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(BIQ) and the Toronto Alexithymia Scale (TAS) can be regarded as having sufficient 
psychometric properties.  
Sifneos (29) devised the Beth Israel Psychosomatic Questionnaire (BIQ) to measure 
alexithymic characteristics. It is a 17-item forced-choice questionnaire completed by the 
therapist. The items are derived from the clinical criteria described previously.  
The TAS is a 20-item self-report scale with strong psychometric properties (33). Subjects 
were asked to indicate the extent to which they agreed or disagreed with each statement 
on a five-point Likert scale. The results are expressed as TAS-20 global scores, as well as 
three subscales measuring difficulty in identifying feelings and distinguishing them from 
bodily sensations of emotion, difficulty expressing feelings, and externally oriented 
thinking. 
The TAS-20 has 3 subscales: 
1. Difficulty Describing Feelings 
2. Difficulty Identifying Feeling 
3. Externally-Oriented Thinking 
7. Treatment in alexithymia 
In treatment situations, therapists find such patients dull and boring (34). Although the 
concept was derived from experience with patients having classic psychosomatic illness, 
this clinical presentation has also been described in patients who somatize (35), who have 
substance abuse disorders (36), and who have experienced severe Psychosomatic 
condition. 
To treatment the alexithymia physicians should focus on developing skills and knowledge 
(vocabulary for emotions, practicing emotional self-awareness). The suffering associated 
with fibromyalgia is intense, and physicians continue to struggle with the management even 
to the extent of prescribing narcotic pain medications where not ideally indicated (37). It 
proposed that much of this suffering will remain unspeakable and untreated until 
management strategies actively consider the prevalence of alexithymia and associated mood 
disorders.  
The therapeutic approach to patients with elevated alexithymia in fibromyalgia includes 
treatment modalities that have the potential for increasing emotional awareness and the 
capacity to regulate and modulate instinctual tensions and emotional arousal through 
cognitive process (38). Such as fantasizing, dreaming, as well as reflective thinking and the 
verbal communication and sharing off feelings.  
The basic idea is that during the process of therapy mental representations of difficult 
situations in patients' lives need to be constructed by putting into words the chain of 
events that makes up the difficult situation making the patient's appraisal of the difficult 
situation explicit; and addressing affective responses and discussing the patient's way of 
dealing with the difficult situation. These three steps reflect principles that should be 
integrated in therapy. In practice, these three steps necessarily get intermingled, and  
we advise against considering them in terms of a protocol or in terms of therapeutic 
phases (33). 
The therapist should first start by asking the patient about his actual life and by exploring 
what goes wrong, with the idea of creating a conversation. Practically speaking, such a 
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conversation focuses on the concrete situations the patient presents as important and 
difficult (trouble at home, an incident with a colleague…). In addressing these events, the 
therapist primarily strives to elicit a factual account that is coherent with the patient's story. 
The aim is to construct the chain of events that makes up specific difficulties, and to create 
an elementary narrative about these difficulties. To construct such narrative, the therapist 
converses with the patient: many open questions are asked, summaries of what has been 
said are frequently given, and a relaxed atmosphere is established. It is important that the 
therapist strives to articulate the difficult situation in the patient's own terms; explicitly 
recognizes the patient's trouble in dealing with the situation; and invites him/her to further 
investigate this problem in therapy. Therapy itself is defined as a place for the investigation 
of difficulties in life. 
As a result, pain and other physical symptoms may influence by different factors including 
alexithymia in patients with fibromyalgia. It thought to be treatment of alexithymia can be 
beneficial in patients with fibromyalgia. Bu it is not possible to fully determine the 
interaction between fibromyalgia and alexithymia.  
Fibromyalgia is a chronic pain syndrome with steadily fluctuating musculo-skeletal pain as 
the main symptom. However, despite intensive research, the primary mechanisms 
underlying the etiopathogenesis of fibromyalgia remain elusive.  
8. Conclusion and future directions 
Alexithymia is a clinical concept that refers to individuals who have difficulty describing 
feelings, have an impoverished fantasy life, and demonstrate a particular style of 
interpersonal relationships. Whether these individuals recognize their emotions but cannot 
express them verbally, or simply cannot recognize these signals from their bodies, is not 
clearly understood. 
The concept itself needs to be more precisely defined, and reliable methods of measurement 
must be developed and validated. If agreement can be reached upon the clinical definition 
and measurement, further studies can be undertaken to evaluate which factors are 
important in the etiology and maintenance of alexithymic behavior. 
In patients with FMS who show the alexithymic trait, attention should be given to the 
establishment of a secure therapeutic alliance. Capacities for regulating emotions on a verbal 
level can only be acquired within an environment based on trust and perceived by the 
patient as safe. The high comorbidity of psychiatric disorders underscores the importance of 
psychiatric interventions in patients with FMS. 
9. References 
[1] Pedrosa Gil F, Weigl M, Wessels T, Irnich D, Baumüller E, Winkelmann A. Parental 
bonding and alexithymia in adults with fibromyalgia. Psychosomatics 
2008;49(2):115-22.  
[2] Yunus MB. Fibromyalgia and overlapping disorders: a unifying concept of central 
sensitivity syndromes. Semin Arthritis Rheum 200;36:339–56. 
[3] Glass J, Park D. Cognitive Function & Fibromyalgia. Monday, April 28, 2003.  
www.intechopen.com
 
New Insights into Fibromyalgia 
 
146 
[4] Julie D, Henry A, Louise H, Phillips B, John R, Crawford B, et all. Summersc Cognitive 
and psychosocial correlates of alexithymia following traumatic brain injury. 
Neuropsychologia 2006;4462–72. 
[5] Hendryx M.S, Haviland M.G, Shaw D.G. Dimensions of alexithymia and their 
relationships to anxiety and depression. Journal of Personality Assessment, 
1991;56(2): 227-37. 
[6] Neyal M.M, Herken H, Demirci H, Virit O, Neyal A. Alexithymic features in migraine 
patients. European Archives of Psychiatry & Clinical Neuroscience 
2004;254(3):182.  
[7] Yucel B, Kora K, Ozyalcin S, Alcalar N, Ozdemir O, Yucel A. Depression, automatic 
thoughts alexithymia and assertiveness in patients with tension-type headache. 
Headache 2002;42:194–9. 
[8] Yalug I, Selekler M, Erdogan A, Kutlu A, Dundar G, Ankaralı H, Aker T. Correlations 
between alexithymia and pain severity, depression, and anxiety among patients 
with chronic and episodic migraine. Psychiatry and Clinical Neurosciences 2010; 
64(3):231–8.  
[9] Stotsky BA. Sodium butabarbital for emotional disorders and insomnia. Dis Nerv Syst 
1972;33(12):798-803. 
[10] Lesser IM. A review of the alexithymia concept. Psychosom Med 1981;43(6):531- 
43. 
[11] Hoppe KD, Bogen JE. Alexithymia in twelve commissurotomized patients. 
Psychotherapy and psychosomatics 1977;28(1–4):148–55. 
[12] Nemiah, CJ. Alexithymia and Psychosomatic Illness. Journal of Continuing Education 
1978;39:25–37. 
[13] Berthoz S, Artiges E, Van de Moortele P, et al. Effect of Impaired Recognition and 
Expression of Emotions on Frontocingulate Cortices: An fMRI Study of Men With 
Alexithymia. American Journal of Psychiatry 2002;159(6): 961-7. 
[14] Wall PDl, Melzack R. The challenge of pain. 2nd ed. New York: Penguin Books; 
1996;pp:61–9. 
[15] Albe-Fessard D, Berkley KJ, Kruger L, Ralston HJ, Willis WD. Diencephalic mechanisms 
of pain sensation. Brain Res Brain Res Rev 1985;9:217–96. 
[16] Lenz FA, Rios M, Zirh A, Chau D, Krauss, Lesser RP. Painful stimuli evoke potentials 
recorded over the human anterior cingulate gyrus. J Neurophysiol 1998;79(4):2231-
4. 
[17] Vogt BA, Nimchinsky EA, Hof PR. Human cingulate cortex: Surface features, flat maps, 
and cytoarchitecture. J Comp Neurol 1997;359:490-506. 
[18] Mountz JM, Bradley LA, Modell JG, Alexander RW, Triana-Alexander M, Aaron LA et 
al. Fibromyalgia in women. Abnormalities of regional cerebral blood flow in the 
thalamus and the caudate nucleus are associated with low pain threshold levels. 
Arthritis Rheum 1995;38(7):926-38. 
[19] Gracely RH, Petzke F, Wolf JM, Clauw DJ. Functional magnetic resonance imaging 
evidence of augmented pain processing in fibromyalgia. Arthritis Rheum 2002;46: 
1333–43. 
www.intechopen.com
 
Alexithymia in Fibromyalgia Syndrome 
 
147 
[20] Jessimer M, Markham R. Alexithymia: a right hemisphere dysfunction specific to 
recognition of certain facial expressions? Brain and Cognition 1997;34(2):246– 
58. 
[21] Lane RD, Ahern GL, Schwartz GE, Kaszniak AW. Is alexithymia the emotional 
equivalent of blindsight? Biol Psychiatry 1997;42(9):834–44.  
[22] Tabibnia G, Zaidel E. Alexithymia, interhemispheric transfer, and right hemispheric 
specialization: a critical review. Psychotherapy and Psychosomatics 2005;74(2):81–
92. 
[23] Maclaren K. Emotional Disorder and the Mind-Body Problem: A Case Study of 
Alexithymia. Chiasmi International 2006;8:139–55. 
[24] Fukunishi I, Berger D, Wogan J, Kuboki T. Alexithymic traits as predictors of difficulties 
with adjustment in an outpatient cohort of expatriates in Tokyo. Psychological 
Reports 1999;85(1):67–77.  
[25] Lane RD, Ahern GL, Schwartz GE, Kaszniak AW. Is alexithymia the emotional 
equivalent of blindsight? Biol Psychiatry 1997;42:834-44. 
[26] Salminen JK, Saarijärvi S, Aärelä E, Toikka T, Kauhanen J. Prevalence of alexithymia 
and its association with sociodemographic variables in the general population of 
Finland. Journal of Psychosomatic Research 1999;46(1):75–82. 
[27] Parker, JDA; Taylor, GJ; Bagby, RM. The Relationship Between Emotional Intelligence 
and Alexithymia. Personality and Individual Differences 2001;30:107–15.  
[28] Pasini, R.D. Chiaie, S. Seripa and N. Ciani, Alexithymia as related to sex, age, and 
educational level: results of the Toronto Alexithymia Scale in 417 normal subjects. 
Compr Psychiatry 1992;33:42–6. 
[29] Sifneos PE, Cambridge MA. Short-term psychotherapy and emotional crisis. Harvard 
University Press; 1972.  
[30] Donald L. Steinweg, F.A.C.P., Apostolos P., Dallas, William S. Rea. Fibromyalgia: 
Unspeakable Suffering, A Prevalence Study of Alexithymia. Psychosomatics 
2011:52:255–62. 
[31] Haviland MG, Warren WL, Riggs ML. An observer scale to measure alexithymia. 
Psychosomatics 2000;41(5):385–92.  
[32] Beales DL, Dolton R. Eating disordered patients: Personality, alexithymia, and 
implications for primary care. British Journal of General Practice 2000;50:21–6. 
[33] Ira M. A review of the alexithymia concept. Lesser Psychosom Med 1981;43(6):531-43. 
[34] Hosoi M, Molton IR, Jensen MP, Ehde DM, Amtmann S, O'Brien S, Arimura T, Kubo C. 
Relationships among alexithymia and pain intensity, pain interference, and vitality 
in persons with neuromuscular disease: Considering the effect of negative 
affectivity. Pain 2010;149(2):273-7. 
[35] Huber A, Suman AL, Biasi G, Carli G. Alexithymia in fibromyalgia syndrome: 
associations with ongoing pain, experimental pain sensitivity and illness behavior. J 
Psychosom Res 2009;66(5):425-33. 
[36] Gur A. Physical therapy modalities in management of fibromyalgia. Curr Pharm Des 
2006;12(1):29-35. 
[37] Bradley LA. Pathophysiology of fibromyalgia. Am J Med 2009;122(12):22-30. 
www.intechopen.com
 
New Insights into Fibromyalgia 
 
148 
[38] Madenci E, Herken H, Keven S, Yagiz E, Gursoy S. Alexıthymıa in patıents wıth 
fıbromyalgıa syndrome. Turkiye Klinikleri J Med Sci 2007;27:32-5. 
www.intechopen.com
New Insights into Fibromyalgia
Edited by Dr. William S. Wilke
ISBN 978-953-307-407-8
Hard cover, 216 pages
Publisher InTech
Published online 05, January, 2012
Published in print edition January, 2012
InTech Europe
University Campus STeP Ri 
Slavka Krautzeka 83/A 
51000 Rijeka, Croatia 
Phone: +385 (51) 770 447 
Fax: +385 (51) 686 166
www.intechopen.com
InTech China
Unit 405, Office Block, Hotel Equatorial Shanghai 
No.65, Yan An Road (West), Shanghai, 200040, China 
Phone: +86-21-62489820 
Fax: +86-21-62489821
Given the potential problems that can obscure any scientific enterprise, inconsistent results across studies are
bound to occur. How are we to decide what is true? Let's turn to philosophy for a reasonable answer. The
mathematician-philosopher Bertrand Russell approached a similar problem in his monograph The Problems of
Philosophy (Russell B, 1912). He addressed the following question: How do we know that anything is "real"? Is
the only reality subjective and simply in our minds, as Bishop Berkley challenged, or can we mostly believe the
objective reality? His pragmatic answer: All possibilities may be true, but when the preponderance of evidence
indicates that objective reality and knowledge are the most probable case, go with it. If the preponderance of
all evidence about the clinical description of fibromyalgia and it's pathogenic mechanisms and treatment
strategies indicate a highly probable interrelated hypothesis, go with it. The direction of the literature on the
whole trumps the less likely tangents. At the same time, remember Bertrand Russell and his pragmatic
answer, and keep an open mind.
How to reference
In order to correctly reference this scholarly work, feel free to copy and paste the following:
Ercan Madenci and Ozlem Altindag (2012). Alexithymia in Fibromyalgia Syndrome, New Insights into
Fibromyalgia, Dr. William S. Wilke (Ed.), ISBN: 978-953-307-407-8, InTech, Available from:
http://www.intechopen.com/books/new-insights-into-fibromyalgia/alexithymia-in-fibromyalgia-syndrome
© 2012 The Author(s). Licensee IntechOpen. This is an open access article
distributed under the terms of the Creative Commons Attribution 3.0
License, which permits unrestricted use, distribution, and reproduction in
any medium, provided the original work is properly cited.
